To evaluate the effect of human SPON1 gene in mice expressing human APP and PSEN1 transgenes with five AD-linked mutations (5xFAD), lentiviral-human SPON1 was injected into the hippocampus and entorhinal cortex (EC) in the early stage of amyloidogenesis. This evidence concerns the gene SPON1 and Alzheimer disease.